| Date |
Title |
Category |
|
| 30/11/2005 | Schering AG CEO buoyant about future profits | Company financials | Read More |
| 22/11/2005 | Merck to buy biotech firm Survac to further cancer research | Company financials | Read More |
| 18/11/2005 | Provalis sales suffer, pharmaceutical arm attracts interest | Company financials | Read More |
| 16/11/2005 | Quintiles net revenue up 19% in 3rd quarter | Company financials | Read More |
| 16/11/2005 | Pharmaceuticals lead the way in European single market | Company financials | Read More |
| 11/11/2005 | Pliva sees net loss of $34 million | Company financials | Read More |
| 10/11/2005 | Lundbeck sees mediocre third quarter earnings | Company financials | Read More |
| 09/11/2005 | Bayer sees profits soar | Company financials | Read More |
| 07/11/2005 | Astellas Pharma sees profits rise 42 per cent | Company financials | Read More |
| 04/11/2005 | Shire Pharmaceuticals spends $624m on R&D as revenues up | Company financials | Read More |
| 04/11/2005 | Merck cleared of Vioxx charges | Company financials | Read More |
| 04/11/2005 | Takeda Pharmaceutical sees profits rise 11 per cent in first half | Company financials | Read More |
| 03/11/2005 | Pfizer best may be past, say analysts | Company financials | Read More |
| 01/11/2005 | Allergan reports third quarter pharma sales up 25 per cent | Company financials | Read More |
